A Multicenter, Double-blind, Randomized, Placebo-Controlled Trial with an Open-Label Extension Phase of Perampanel as Adjunctive Treatment in Subjects at Least 2 years of Age with Inadequate Controlled Seizures Associated with Lennox-Gastaut Syndrome.